Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488, 12984 [2022-04787]
Download as PDF
12984
Federal Register / Vol. 87, No. 45 / Tuesday, March 8, 2022 / Notices
Drug Enforcement
Administration, Department of Justice.
ACTION: 60-Day notice.
—Evaluate whether the proposed
collection of information is
necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical
utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information proposed to be collected
can be enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
The Drug Enforcement
Administration (DEA), Department of
Justice, will be submitting the following
information collection request to the
Office of Management and Budget for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This information collection is also
associated with the proposed
rulemaking ‘‘Management of Quotas for
Controlled Substances and List I
Chemicals,’’ published in the Federal
Register. It is likely that the final rule
will not be published before this
information collection expires on May
31, 2022. If the final rule does publish
prior to the expiration, it will be
published as the 30-Day Notice.
DATES: Comments are encouraged and
will be accepted for 60 days until May
9, 2022.
FOR FURTHER INFORMATION CONTACT: If
you have comments, especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Scott A. Brinks, Regulatory
Drafting and Policy Support Section
(DPW), Diversion Control Division, Drug
Enforcement Administration; Mailing
Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone:
(571) 776–2265.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Application for Import Quota for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
DEA Form 488. The applicable
component within the Department of
Justice is the Drug Enforcement
Administration, Diversion Control
Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Affected public (Primary): Business or
other for-profit.
Affected public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Pursuant to 21 U.S.C. 952
and 21 CFR 1315.34, any person who
desires to import the List I chemicals
Ephedrine, Pseudoephedrine, or
Phenylpropanolamine during the next
calendar year must apply on DEA Form
488 for an import quota for each such
List I chemical.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The DEA estimates 49
respondents complete 126 DEA Form
488 applications annually, and that each
form takes 0.5 hours to complete.
Respondents complete a separate DEA
Form 488 for each List I chemical for
which quota is sought.
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2022–04785 Filed 3–7–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0047]
Agency Information Collection
Activities; Proposed eCollection,
eComments Requested; Extension
Without Change of a Previously
Approved Collection; Application for
Import Quota for Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine; DEA Form 488
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:25 Mar 07, 2022
Jkt 256001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
6. An estimate of the total public
burden (in hours) associated with the
proposed collection: The DEA estimates
this collection takes a total of 63 annual
burden hours.
If additional information is required,
please contact: Melody Braswell,
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, Suite 3E.405B,
Washington, DC 20530.
Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2022–04787 Filed 3–7–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging Proposed Consent
Decree
In accordance with Departmental
Policy, 28 CFR 50.7, notice is hereby
given that a proposed Consent Decree in
United States v. Polo Development, Inc.,
et al., Civil Action No. 4:20–cv–2400–
JRA, was lodged with the United States
District Court for the Northern District
of Ohio on March 1, 2022.
This proposed Consent Decree
concerns an amended complaint filed
by the United States against Defendants
Polo Development, Inc., AIM Georgia,
LLC, Joseph Zdrilich, Donna Zdrilich,
and Carbon Hills, LLC, pursuant to
Section 309(b) of the Clean Water Act,
33 U.S.C. 1319(b), to obtain injunctive
relief from and impose civil penalties
against the Defendants for violating
Section 301(a) of the Clean Water Act,
33 U.S.C. 1311(a), by discharging
pollutants without a permit into waters
of the United States. The proposed
Consent Decree resolves these claims by
requiring the Defendants to restore
impacted areas, record a conservation
easement, and pay a civil penalty.
The Department of Justice will accept
written comments relating to this
proposed Consent Decree for thirty (30)
days from the date of publication of this
Notice. Please address comments to
Patrick R. Jacobi, United States
Department of Justice, Environment and
Natural Resources Division,
Environmental Defense Section, Denver
Place Building, 999 18th Street, Suite
370—South Terrace, Denver, CO 80202,
pubcomment_eds.enrd@usdoj.gov, and
refer to United States v. Polo
Development, Inc., et al., DJ #’s 90–5–1–
1–21099, 90–5–1–1–22034.
Subject to public health protocols, the
proposed Consent Decree may be
E:\FR\FM\08MRN1.SGM
08MRN1
Agencies
[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Page 12984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04787]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0047]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Application for Import Quota for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine; DEA Form 488
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice, will be submitting the following information collection
request to the Office of Management and Budget for review and approval
in accordance with the Paperwork Reduction Act of 1995. This
information collection is also associated with the proposed rulemaking
``Management of Quotas for Controlled Substances and List I
Chemicals,'' published in the Federal Register. It is likely that the
final rule will not be published before this information collection
expires on May 31, 2022. If the final rule does publish prior to the
expiration, it will be published as the 30-Day Notice.
DATES: Comments are encouraged and will be accepted for 60 days until
May 9, 2022.
FOR FURTHER INFORMATION CONTACT: If you have comments, especially on
the estimated public burden or associated response time, suggestions,
or need a copy of the proposed information collection instrument with
instructions or additional information, please contact Scott A. Brinks,
Regulatory Drafting and Policy Support Section (DPW), Diversion Control
Division, Drug Enforcement Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-
2265.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection
1. Type of Information Collection: Extension of a currently
approved collection.
2. Title of the Form/Collection: Application for Import Quota for
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: DEA Form 488. The applicable
component within the Department of Justice is the Drug Enforcement
Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: Pursuant to 21 U.S.C. 952 and 21 CFR 1315.34, any person
who desires to import the List I chemicals Ephedrine, Pseudoephedrine,
or Phenylpropanolamine during the next calendar year must apply on DEA
Form 488 for an import quota for each such List I chemical.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
49 respondents complete 126 DEA Form 488 applications annually, and
that each form takes 0.5 hours to complete. Respondents complete a
separate DEA Form 488 for each List I chemical for which quota is
sought.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates this collection takes a
total of 63 annual burden hours.
If additional information is required, please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2022-04787 Filed 3-7-22; 8:45 am]
BILLING CODE 4410-09-P